COST-EFFECTIVENESS OF DRUG ABUSE TREATMENT: RELEVANT ISSUES AND ALTERNATIVE LONGITUDINAL MODELING APPROACHES. EN: ECONOMIC COSTS, COST-EFFECTIVENESS, FINANCING, AND COMMUNITY-BASED DRUG TREATMENT
Wedi'i Gadw mewn:
HSER, Y.I., ANGLIN, M.D., COST-EFFECTIVENESS OF DRUG ABUSE TREATMENT: RELEVANT ISSUES AND ALTERNATIVE LONGITUDINAL MODELING APPROACHES. EN: ECONOMIC COSTS, COST-EFFECTIVENESS, FINANCING, AND COMMUNITY-BASED DRUG TREATMENT. ROCKVILLE,MD (USA), NATIONAL INSTITUTE ON DRUG ABUSE, 1991, 67-93 p.
Ref.
35327
Lleoliad:
SIIS Q1.104 D93.3
Palabras clave:
Análisis coste-eficacia, Drogodependencias, Estudio longitudinal, Metodología, Modelos, Tratamiento, EE.UU.
Análisis coste-eficacia, Drogodependencias, Estudio longitudinal, Metodología, Modelos, Tratamiento, EE.UU.
Eitemau Tebyg: COST-EFFECTIVENESS OF DRUG ABUSE TREATMENT: RELEVANT ISSUES AND ALTERNATIVE LONGITUDINAL MODELING APPROACHES. EN: ECONOMIC COSTS, COST-EFFECTIVENESS, FINANCING, AND COMMUNITY-BASED DRUG TREATMENT
- EVALUATING THE COST-EFFECTIVENESS OF DRUG ABUSE TREATMENT SERVICES. EN: ECONOMIC COSTS, COST-EFFECTIVENESS, FINANCING, AND COMMUNITY-BASED DRUG TREATMENT
- POLICY-RELEVANT RESEARCH ON DRUG TREATMENT. EN: ECONOMIC COSTS, COST-EFFECTIVENESS, FINANCING, AND COMMUNITY-BASED DRUG TREATMENT
- COST-EFFECTIVENESS OF DRUG ABUSE TREATMENT FOR PRIMARY PREVENTION OF ACQUIRED IMMUNODEFICIENCY SYNDROME: EPIDEMIOLOGIC CONSIDERATIONS. EN: ECONOMIC COSTS, COST-EFFECTIVENESS, FINANCING, AND COMMUNITY-BASED DRUG TREATMENT
- ECONOMIC COSTS, COST-EFFECTIVENESS, FINANCING, AND COMMUNITY-BASED DRUG TREATMENT. NIDA RESEARCH MONOGRAPH SERIES Nº 113
- FINANCING TREATMENT FOR SUBSTANCE ABUSE. EN: ECONOMIC COSTS, COST-EFFECTIVENESS, FINANCING, AND COMMUNITY-BASED DRUG TREATMENT
- FORECASTING THE COST OF DRUG ABUSE TREATMENT COVERAGE IN PRIVATE HEALTH INSURANCE. EN: ECONOMIC COSTS, COST-EFFECTIVENESS, FINANCING, AND COMMUNITY-BASED DRUG TREATMENT